Company Filing History:
1 out of 5 
1 out of 7 Years Active: 2007
Title: Innovations of Chun Mei Shu in Pharmaceutical Chemistry
Introduction
Chun Mei Shu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medical treatments. His work has led to advancements in the preparation of tamsulosin and its derivatives, which are crucial for treating prostate-related conditions.
Latest Patents
Chun Mei Shu holds a patent for a process for the preparation of tamsulosin and its aralkylamine derivatives. This invention discloses a new synthesis method for tamsulosin, specifically targeting the production of (R)-(-)-5-{2-[2-(2-alkoxyphenoxy)ethylamino]propyl}-2-alkoxybenzenesulfonamides. The patent highlights the hydrochloride form of tamsulosin, which acts as an antagonist of α-A adrenoceptors in the prostate. Tamsulosin hydrochloride is characterized by its white crystalline form, melting with decomposition at approximately 230°C, and its solubility properties in various solvents.
Career Highlights
Throughout his career, Chun Mei Shu has worked with prominent companies in the biotechnology sector, including Well-being Biochemical Corporation and Taiwan Biotech Co., Ltd. His expertise in pharmaceutical synthesis has positioned him as a valuable asset in these organizations, contributing to innovative drug development.
Collaborations
Chun Mei Shu has collaborated with several professionals in his field, including Ru Hwu Jih and Shwu Chen Tsay. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in pharmaceutical chemistry.
Conclusion
Chun Mei Shu's contributions to the synthesis of tamsulosin and its derivatives exemplify the importance of innovation in the pharmaceutical industry. His work not only advances medical treatments but also showcases the potential of collaboration in scientific research.